Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BiogenNOVOZYMES A/S/SSeattle GeneticsNeurocrine BiosciencesQiagen
SymbolNASDAQ:BIIBOTCMKTS:NVZMYNASDAQ:SGENNASDAQ:NBIXNYSE:QGEN
Price Information
Current Price$224.94$42.75$85.85$96.83$28.11
52 Week RangeHoldHoldBuyBuyHold
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyHold
Consensus Price Target$266.75N/A$87.92$106.56$34.86
% Upside from Price Target18.59% upsideN/A2.41% upside10.04% upside24.00% upside
Trade Information
Market Cap$41.70 billion$13.31 billion$13.48 billion$8.56 billion$6.20 billion
Beta1.020.751.951.220.85
Average Volume1,836,74230,3901,080,687634,3402,160,052
Sales & Book Value
Annual Revenue$13.45 billion$2.28 billion$654.70 million$451.24 million$1.50 billion
Price / Sales3.085.5721.2119.654.22
Cashflow$31.59 per share$1.64 per shareN/A$0.52 per share$2.51 per share
Price / Cash7.1226.02N/A186.4911.20
Book Value$64.68 per share$6.10 per share$7.95 per share$5.30 per share$11.69 per share
Price / Book3.487.0110.8018.272.40
Profitability
Net Income$4.43 billion$511 million$-222,690,000.00$21.11 million$190.38 million
EPS$26.20$1.75($1.65)$0.22$1.34
Trailing P/E Ratio8.5924.43N/A440.1420.98
Forward P/E Ratio6.9825.91N/A28.8218.37
P/E Growth$1.11$2.12N/A$5.76$1.97
Net Margins37.62%22.31%-36.94%2.98%12.94%
Return on Equity (ROE)44.89%28.54%-17.16%0.46%12.10%
Return on Assets (ROA)23.23%16.00%-14.39%0.21%5.76%
Dividend
Annual PayoutN/A$0.50N/AN/AN/A
Dividend YieldN/A1.17%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A28.57%N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.49%0.05%N/A0.96%0.54%
Current Ratio2.46%1.27%3.03%7.44%1.77%
Quick Ratio2.22%0.75%2.70%7.32%1.59%
Ownership Information
Institutional Ownership Percentage86.27%0.18%98.93%96.09%62.09%
Insider Ownership Percentage0.39%N/A33.80%4.30%9.00%
Miscellaneous
Employees7,8006,4271,3025854,952
Shares Outstanding184.45 million297.00 million161.72 million91.58 million225.51 million
Next Earnings Date10/22/2019 (Confirmed)10/23/2019 (Confirmed)10/29/2019 (Confirmed)11/4/2019 (Confirmed)10/30/2019 (Confirmed)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 BiogenNOVOZYMES A/S/SSeattle GeneticsNeurocrine BiosciencesQiagen

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel